Granules India gains key FDA approval for Unit V facility, marking major compliance milestone

Pallavi Madhiraju- November 8, 2024 0

Hyderabad-based Granules India Limited has achieved a significant regulatory milestone, securing an Establishment Inspection Report (EIR) with a “No Action Indicated” (NAI) status from the ... Read More

Glenmark Life Sciences’ Q1FY25 results shock industry with 9.7% revenue surge

Pallavi Madhiraju- July 26, 2024 0

Glenmark Life Sciences Limited (BSE: 543322, NSE: GLS), a prominent player in the pharmaceutical industry, has announced impressive financial results for the quarter ended June ... Read More